About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ASCO Breakthrough: A Global Summit for Oncology Innovators
ESMO 2019 Congress
NCCN 2019 Annual Congress: Hematologic Malignancies
2019 ASTRO Annual Meeting
IASLC 2019 World Conference on Lung Cancer
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Tim Donald, ELS"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
High Conversion Rate With Certain Induction Chemotherapy Regimens is Associated With Improved OS in LAPC
AMG 510 for KRAS G12C–Mutated, Advanced NSCLC
FDA Pipeline: Advances in Prostate Cancer, Urothelial Cancer, Myelofibrosis, and More
3-Year Results From CheckMate 238: Adjuvant Nivolumab vs Ipilimumab in Advanced Melanoma
Complete Mesocolic Excision in Right-Sided Colon Cancer
Most Read Stories
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): 2016 Guidelines
Management of HER2-Positive Breast Cancer: Business as Usual?
The Future of the Radiation Abscopal Response
RELAY Trial: Addition of Ramucirumab to Erlotinib in Previously Untreated,
-Mutated Advanced NSCLC
ASCO Breakthrough: Effect of
Mutations on Response to Radiotherapy
© 2019 HSP News Service, L.L.C.